Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 1998

View Archived Issues

Roberts seeks to broaden market for Agrylin

Sumitomo and Genentech collaborate on two GH products

Ribozyme HIV gene therapy demonstrates potential in phase I/II

Chemogene therapy: a new therapeutic approach on the horizon?

Cellegy acquires Anogesic

Advanced Polymer Systems and Pharmacia & Upjohn collaborate on new drug formulation

Audit of Genzyme Transgenics' rhATIII production facility triggers milestone

OrthoLogic makes equity investment in Chrysalis; acquires rights to new peptide

Efficacy established for ET antagonist in pulmonary hypertension

New muscarinic receptor modulators from Lilly

Novo Nordisk discloses peripheral muscarinic cholinergic agonists

Lusofarmaco develops new angiotensin antagonists

Selective COX-2 inhibitors under study at Merck Frosst

GH release-stimulating compounds reported by Novo Nordisk

Akzo patents benzylamines for depression

Potent, selective protein tyrosine kinase inhibitors for immune and hyperproliferative disorders

Pharmacia & Upjohn prepares MMP inhibitors

Temodal submitted for approval in E.U.

Two new launches for Emdogain

IND submitted for new atherosclerosis imaging agent from Diatide

GeneMedicine will not conduct scheduled clinical trial of IGF-I Gene Medicine

Synaptic and Gruenenthal initiate pain collaboration

Analog II: a novel antiestrogen with selective activity against breast cancer

New anticancer combination associated with high efficacy in phase II metastatic breast cancer trial

Takeda announces changes in Japanese and European business strategies

Neupogen approved for use in AIDS patients

ProAmatine filed for approval in U.K.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...